Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -27.67% is 656% below its 5-year average of -3.66%, around the middle of its 5-year range (-59.28%–12.74%).
20.25% above its 12-month average of -34.70%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -24.41%.
OPERATING MARGIN
-27.67%
OPERATING MARGIN AVG TTM
-34.70%
OPERATING MARGIN AVG 3Y
-12.36%
OPERATING MARGIN AVG 5Y
-3.66%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+20.25%
CURRENT VS 3Y AVG
-123.79%
CURRENT VS 5Y AVG
-656.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 744 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
DocGo Inc.
Market Cap
$35.92M
Operating Margin
-27.67%
TTM Avg
-34.70%
3Y Avg
-12.36%
5Y Avg
-3.66%
Market Cap
$36.63M
Operating Margin
-17.45%
TTM Avg
-136.53%
3Y Avg
-3170.70%
5Y Avg
-2922.37%
Market Cap
$36.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-343.01%
Market Cap
$35.15M
Operating Margin
-149.78%
TTM Avg
-148.02%
3Y Avg
-141.74%
5Y Avg
-107.90%
Market Cap
$37.76M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-324.45%
Market Cap
$34.97M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$34.58M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1396.17%
Market Cap
$34.33M
Operating Margin
-6.58%
TTM Avg
-2.44%
3Y Avg
-1.06%
5Y Avg
0.55%
Market Cap
$38.35M
Operating Margin
0.00%
TTM Avg
-13830.82%
3Y Avg
-69500.82%
5Y Avg
-46675.05%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DocGo Inc. (DCGO) | $35.92M | -27.67% | -34.70% | -12.36% | -3.66% |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.63M | -17.45% | -136.53% | -3170.70% | -2922.37% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.70M | 0.00% | 0.00% | 0.00% | -343.01% |
| Elutia Inc (ELUT)vs › | $35.15M | -149.78% | -148.02% | -141.74% | -107.90% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.76M | 0.00% | 0.00% | 0.00% | -324.45% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | 0.00% | 0.00% | 0.00% | -1396.17% |
| Accuray Incorporated (ARAY)vs › | $34.33M | -6.58% | -2.44% | -1.06% | 0.55% |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | 0.00% | -13830.82% | -69500.82% | -46675.05% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.23M | -4024.93% | -3142.43% | -1888.50% | -1749.64% |
Gross Margin
30.1%
Operating Margin
-27.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -24.41% |
| 2026-03-31 | -24.77% |
| 2025-12-31 | -43.29% |
| 2025-09-30 | -59.28% |
| 2025-06-30 | -21.74% |
| 2025-03-31 | -14.58% |
| 2024-12-31 | -6.18% |
| 2024-09-30 | 7.31% |
| 2024-06-30 | 6.15% |
| 2024-03-31 | 8.26% |
| 2023-12-31 | 5.86% |
| 2023-09-30 | 4.67% |
| 2023-06-30 | 1.26% |
| 2023-03-31 | -6.11% |
| 2022-12-31 | 0.07% |
| 2022-09-30 | 4.03% |
| 2022-06-30 | 6.81% |
| 2022-03-31 | 8.56% |
| 2021-12-31 | 12.74% |
| 2021-09-30 | 1.77% |
| 2021-06-30 | 0.42% |
| 2021-03-31 | -3.77% |
| 2020-12-31 | -14.21% |
| 2020-09-30 | -9.50% |
| 2020-06-30 | -7.60% |
| 2020-03-31 | -45.12% |
